Quantason

Quantason is a pioneering company in the field of medical imaging, specializing in advanced ultrasound technologies for breast cancer detection and monitoring. The company serves healthcare providers, including hospitals and diagnostic centers, operating primarily in the medical imaging market. Quantason's core product, IDUS™ (Integrated Diagnostic Ultrasound System), offers a dual-mode operation: high-fidelity 2D/3D ultrasound imaging and real-time acoustic spectral analysis. This technology enables the early detection of ductal carcinoma in situ (DCIS) and monitors its progression, which is crucial for timely intervention and treatment. Quantason generates revenue through the sale of its ultrasound systems and related services, targeting institutions that require cutting-edge diagnostic tools for breast cancer care. The company's business model focuses on innovation and collaboration with leading medical experts to continuously enhance its product offerings.

Keywords: ultrasound, breast cancer, 2D/3D imaging, acoustic spectral analysis, DCIS detection, medical imaging, healthcare providers, diagnostic centers, early detection, advanced technology.